Correlation Between Dun Bradstreet and Bristol Myers

Can any of the company-specific risk be diversified away by investing in both Dun Bradstreet and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dun Bradstreet and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dun Bradstreet Holdings and Bristol Myers Squibb, you can compare the effects of market volatilities on Dun Bradstreet and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dun Bradstreet with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dun Bradstreet and Bristol Myers.

Diversification Opportunities for Dun Bradstreet and Bristol Myers

-0.41

Correlation Coefficient

Dun Bradstreet  Bristol Myers

Very good diversification

The 3 months correlation between Dun and Bristol is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Dun Bradstreet Holdings and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Dun Bradstreet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dun Bradstreet Holdings are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Dun Bradstreet i.e., Dun Bradstreet and Bristol Myers go up and down completely randomly.

Pair Corralation between Dun Bradstreet and Bristol Myers

Considering the 90-day investment horizon Dun Bradstreet Holdings is expected to generate 1.53 times more return on investment than Bristol Myers. However, Dun Bradstreet is 1.53 times more volatile than Bristol Myers Squibb. It trades about 0.0 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.09 per unit of risk. If you would invest  962.00  in Dun Bradstreet Holdings on January 19, 2024 and sell it today you would lose (47.00) from holding Dun Bradstreet Holdings or give up 4.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.56%
Values	Daily Returns

Dun Bradstreet Holdings  vs.  Bristol Myers Squibb

Dun Bradstreet Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dun Bradstreet Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Bristol Myers Squibb

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Dun Bradstreet and Bristol Myers

The main advantage of trading using opposite Dun Bradstreet and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dun Bradstreet position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.

The idea behind Dun Bradstreet Holdings and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.